Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Annual Inhaled Drug Delivery Conference.

Leone-Bay A, Smutney C.

Ther Deliv. 2011 Feb;2(2):157-8.

PMID:
22833940
2.
3.

Dry powder inhalers for optimal drug delivery.

Newman SP.

Expert Opin Biol Ther. 2004 Jan;4(1):23-33. Review.

PMID:
14680466
4.

New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy.

Onoue S, Misaka S, Kawabata Y, Yamada S.

Expert Opin Drug Deliv. 2009 Aug;6(8):793-811. doi: 10.1517/17425240903089310. Review.

PMID:
19558334
6.

Challenges and opportunities in respiratory drug delivery devices.

Nikander K.

Expert Opin Drug Deliv. 2010 Nov;7(11):1235-8. doi: 10.1517/17425247.2010.525231. Epub 2010 Oct 12.

PMID:
20939686
7.

Asthma & COPD - SMi's sixth annual conference.

Shah S.

IDrugs. 2010 Jun;13(6):376-8.

PMID:
20506058
8.

Impact of regular inhaled corticosteroid use on chronic obstructive pulmonary disease outcomes.

Vollmer WM, Peters D, Crane B, Kelleher C, Buist AS.

COPD. 2007 Jun;4(2):135-42.

PMID:
17530507
9.

Inhalation delivery systems with compliance and disease management capabilities.

Gonda I, Schuster JA, Rubsamen RM, Lloyd P, Cipolla D, Farr SJ.

J Control Release. 1998 Apr 30;53(1-3):269-74.

PMID:
9741934
10.

Asthma & COPD--IQPC's Second Conference.

Catley MC.

IDrugs. 2010 Sep;13(9):601-4.

PMID:
20799138
11.

Inhaler technique and training in people with chronic obstructive pulmonary disease and asthma.

Capstick TG, Clifton IJ.

Expert Rev Respir Med. 2012 Feb;6(1):91-101; quiz 102-3. doi: 10.1586/ers.11.89. Review.

PMID:
22283582
12.

[Secondary osteoporosis: Inhaled corticosteroids induced osteoporosis in respiratory diseases].

Ieda Y, Nagasaka Y.

Clin Calcium. 2007 Jun;17(6):955-62. Review. Japanese.

PMID:
17548937
13.

Novel and current treatment concepts using pulmonary drug delivery.

Hohenegger M.

Curr Pharm Des. 2010;16(22):2484-92. Review.

PMID:
20509845
14.

[Inhaled therapy via nebulization: practical issues].

Antoniu S, Bararu T, Zizilaş G, Mihăescu T.

Pneumologia. 2007 Jul-Sep;56(3):143-6. Review. Romanian.

PMID:
18019975
15.

The paradox of respiratory R&D, and why 'inhaled-by-design' heralds a new dawn in asthma and chronic obstructive pulmonary disease treatments.

Yeadon M.

Future Med Chem. 2011 Oct;3(13):1581-3. doi: 10.4155/fmc.11.97. No abstract available.

PMID:
21942249
16.

[Inhaled glucocorticosteroids in the treatment of asthma and chronic obstructive pulmonary disease].

Obojski A, Dobek R, Panaszek B.

Pneumonol Alergol Pol. 2004;72(5-6):226-32. Review. Polish.

PMID:
15757265
17.
18.

Effects of inhaled therapies on health-related quality of life in stable chronic obstructive pulmonary disease.

Antoniu SA.

Expert Rev Pharmacoecon Outcomes Res. 2010 Apr;10(2):155-62. doi: 10.1586/erp.10.11. Review.

PMID:
20384562
19.

Delivery of antibiotics to the respiratory tract: an update.

Traini D, Young PM.

Expert Opin Drug Deliv. 2009 Sep;6(9):897-905. doi: 10.1517/17425240903110710. Review.

PMID:
19637984
20.

Inhaled corticosteroids in obstructive airway disease.

Phua GC, Macintyre NR.

Respir Care. 2007 Jul;52(7):852-8. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk